From: Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification
Gene
n
Rank Sum (Treatment)
Rank Sum (Control)
p-value
(Treatment)
(Control)
MMP-9
36
415
251
0.0095
CD24
443
223
0.0005
Lactoferrin
460
206
0.0001
Lipocalin 2
419
247
0.0065